Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.

NCT06117020 is registered in ClinicalTrials.gov with Motric Bio as lead sponsor.

NCT NCT06117020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06117020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.
Lead sponsor
Motric Bio
Phase
Phase 1
Overall status
Completed
Start date
September 11, 2023
Completion date
October 16, 2024
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, dystonia, hereditary spastic paraplegia, hypertonia, muscle, multiple sclerosis, muscle spasticity, spinal cord injuries, stroke